Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Microbiotica, a UK-based developer of microbiome-based therapeutics and biomarkers spun out of Wellcome Sanger Institute, completed a £50m ($66.6m) series B round backed by commercialisation firm IP Group and patient capital fund Cambridge Innovation Capital (CIC) today. The round included internet group Tencent, as well as Flerie Invest, British Patient Capital and Seventure Partners. Seventure previously injected $5.2m in 2018, two years after Microbiotica was established with $10m from CIC and IP Group.
Tenyks, a UK-based spinout of…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
